Literature DB >> 3283179

Mode of action, and in vitro and in vivo activities of the fluoroquinolones.

P B Fernandes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3283179     DOI： 10.1002/j.1552-4604.1988.tb05967.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  15 in total

1.  Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeons.

Authors:  H C Neu
Journal:  Tex Heart Inst J       Date:  1990

2.  Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves.

Authors:  M ismail
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

3.  The effect of induced fever on the biokinetics of norfloxacin and its interaction with probenecid in goats.

Authors:  K Jha; B K Roy; R C Singh
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

4.  Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.

Authors:  G E Kenny; T M Hooton; M C Roberts; F D Cartwright; J Hoyt
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

5.  Neurotoxicodynamics of the interaction between ciprofloxacin and foscarnet in mice.

Authors:  H Matsuo; M Ryu; A Nagata; T Uchida; J I Kawakami; K Yamamoto; T Iga; Y Sawada
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 6.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of Dicural.

Authors:  A M Abd El-Aty; A Goudah; M Ismail; M Shimoda
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

8.  DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs.

Authors:  L L Shen; J Baranowski; J Fostel; D A Montgomery; P A Lartey
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

9.  Ofloxacin compared with chloramphenicol in the management of external ocular infection.

Authors:  A J Bron; G Leber; S N Rizk; H Baig; A R Elkington; G R Kirkby; C Neoh; A Harden; T Leong
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

10.  Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.

Authors:  A Gwon
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.